[2023][2022][2021] [2020] [2019] [2018] [2017]
2023年
準備中
2022年
Ozeki Y, Kanogawa N, Ogasawara S, Ogawa K, Ishino T, Nakagawa M, Fujiwara K, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Kojima R, Kanzaki H, Koroki K, Kobayashi K, Nakamura M, Kiyono S, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Nakamoto S, Muroyama R, Tawada A, Chiba T, Arai M, Kato J, Ikeda JI, Takiguchi Y, Kato N. Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis. Int J Clin Oncol. 2022 Sep;27(9):1459-1466. doi: 10.1007/s10147-022-02195-9. Epub 2022 Jun 15. PMID: 35704154.
Matsushima J, Sato T, Ohnishi T, Yoshimura Y, Mizutani H, Koto S, Ikeda JI, Kano M, Matsubara H, Hayashi H. The Use of Deep Learning-Based Computer Diagnostic Algorithm for Detection of Lymph Node Metastases of Gastric Adenocarcinoma. Int J Surg Pathol. 2022 Jul 27:10668969221113475. doi: 10.1177/10668969221113475. Epub ahead of print. PMID: 35898183.
Isshiki Y, Oshima M, Mimura N, Kayamori K, Miyamoto-Nagai Y, Seki M, Nakajima-Takagi Y, Kanamori T, Iwamoto E, Muto T, Tsukamoto S, Takeda Y, Ohwada C, Misawa S, Ikeda JI, Sanada M, Kuwabara S, Suzuki Y, Sakaida E, Nakaseko C, Iwama A. Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis. JCI Insight. 2022 Oct 24;7(20):e151482. doi: 10.1172/jci.insight.151482. PMID: 36129760; PMCID: PMC9714781.
Kusumoto S, Ikeda JI, Kurashige M, Maeno-Fujinami E, Tahara S, Matsui T, Nojima S, Okuzaki D, Morii E. Tumor cell plasticity in endometrioid carcinoma is regulated by neuronal membrane glycoprotein M6-b. Oncol Lett. 2022 Dec 14;25(2):45. doi: 10.3892/ol.2022.13631. PMID: 36644159; PMCID: PMC9811623.
Akutsu A, Horikoshi T, Yokota H, Wada T, Motoori K, Nasu K, Yamasaki K, Hanazawa T, Ikeda JI, Uno T. MR Imaging Findings of Carcinoma Ex Pleomorphic Adenoma Related to Extracapsular Invasion and Prognosis. AJNR Am J Neuroradiol. 2022 Nov;43(11):1639-1645. doi: 10.3174/ajnr.A7656.
Ohyama H, Mikata R, Hirotsu Y, Amemiya K, Miura Y, Hirose S, Oyama T, Takano A, Iimuro Y, Kojima Y, Mochizuki H, Ikeda J, Kato N, Omata M. Genomic profiling amplifies the utility of endoscopic ultrasound-guided fine needle biopsy by identifying clinically applicable druggable mutations in pancreatic cancer.Ann Diagn Pathol. 2022 Oct;60:152016. doi: 10.1016/j.anndiagpath.2022.152016. Epub 2022 Jul 22.
Yonemoto S, Uesato M, Nakano A, Murakami K, Toyozumi T, Maruyama T, Suito H, Tamachi T, Kato M, Kainuma S, Matsusaka K, Matsubara H. Why is endosonography insufficient for residual diagnosis after neoadjuvant therapy for esophageal cancer? Solutions using muscle layer evaluation. World J Gastrointest Endosc. 2022 May 16;14(5):320-334. doi: 10.4253/wjge.v14.i5.320. PMID: 35719903; PMCID: PMC9157697.
Inoue T, Matsuda K, Matsusaka K, Nakajima M, Takeno Y, Miyazaki T, Shintaku T, Yoda N, Saito T, Ikeda E, Mano Y, Shinohara K, Rahmutulla B, Fukuyo M, Kita K, Nemoto T, Kaneda A. Anti-proliferating and apoptosis-inducing activity of chemical compound FTI-6D in association with p53 in human cancer cell lines. Chem Biol Interact. 2023 Jan 5;369:110257. doi: 10.1016/j.cbi.2022.110257. Epub 2022 Nov 11. PMID: 36375514.
Goto C, Okimoto K, Matsusaka K, Matsumura T, Akizue N, Ohta Y, Taida T, Saito K, Kato J, Kato N. Long-term vonoprazan administration causes gastric fundic gland-type hyperplastic polyps and chronic bleeding. Clin J Gastroenterol. 2022 Dec 31. doi: 10.1007/s12328-022-01751-0. Epub ahead of print. PMID: 36586091.
Yasuda M, Yamanaka Y, Kano H, Araki N, Ishikawa H, Ikeda JI, Kuwabara S. Recurrent Cerebral Infarcts Associated with Uterine Adenomyosis: Successful Prevention by Surgical Removal. Intern Med. 2022 Mar 1;61(5):735-738. doi: 10.2169/internalmedicine.7320-21. Epub 2021 Sep 4. PMID: 34483206; PMCID: PMC8943379.
Kouchi Y, Komatsu S, Harada S, Shinomiya Y, Ikeda JI, Kishimoto T. Ovarian Malignant Mixed Germ Cell Tumor Composed Mainly of a Polyembryoma Pattern With Vasculogenic Mesenchymal Tumor Components. Int J Gynecol Pathol. 2023 Jan 1;42(1):78-82. doi: 10.1097/PGP.0000000000000867. Epub 2022 Apr 12. PMID: 35512212.
Kawame C, Yokota H, Shikano K, Kasai H, Suzuki M, Abe M, Kishimoto T, Ikeda JI, Sakao S, Suzuki T. Pneumocystis pneumonia in an immunocompetent patient developing a subacute disease course with central consolidation. Respir Med Case Rep. 2022 May 1;37:101659. doi: 10.1016/j.rmcr.2022.101659. PMID: 35573976; PMCID: PMC9097713.
Kameda E, Matsuzawa T, Togawa Y, Ikeda JI, Matsue H. Case of pigmented onychomatricoma: A relationship between dermoscopic and pathological findings. J Dermatol. 2022 Oct;49(10):e397-e398. doi: 10.1111/1346-8138.16474. Epub 2022 May 26. PMID: 35616131.
Sasaki M, Hirono S, Gao Y, Suda I, Matsutani T, Ota M, Kishimoto T, Ikeda JI, Yokoo H, Iwadate Y. Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of EWSR1-CREM Gene Fusion and MAP3K13 Mutation: A Case Report and Comparison with Adult Cases in the Literature. NMC Case Rep J. 2022 May 18;9:101-109. doi: 10.2176/jns-nmc.2021-0385. PMID: 35693189; PMCID: PMC9177164.
Kouchi Y, Takayashiki T, Harada S, Shinomiya Y, Nasu K, Ikeda JI, Ohtsuka M, Kishimoto T. Adenocarcinoma arising in an adrenohepatic fusion-related cyst. Pathol Int. 2022 Aug;72(8):426-429. doi: 10.1111/pin.13238. Epub 2022 Jun 13. PMID: 35694849.
Imai S, Kasai H, Sugiura T, Nagata J, Toyoda T, Shiohira S, Shikano K, Kawame C, Kouchi Y, Ota M, Abe M, Suzuki H, Ikeda JI, Yoshino I, Suzuki T. A case of primary racemose hemangioma with endobronchial lesions demonstrating recurrent hemoptysis initially treated with bronchial arterial embolization. Respir Med Case Rep. 2022 Oct 25;40:101762. doi: 10.1016/j.rmcr.2022.101762. PMID: 36340866; PMCID: PMC9630766.
Niwano A, Sasaki H, Takaoka H, Kawasaki K, Atarashi K, Ikeda JI, Matsumiya G, Matsushita K, Kobayashi Y. Extremely rare rapid development of a papillary fibroelastoma on the left ventricular anterior papillary muscle. J Cardiol Cases. 2022 Sep 9;26(6):404-406. doi: 10.1016/j.jccase.2022.08.010. PMID: 36506498; PMCID: PMC9727561.
Kurata Y, Hayano K, Matsusaka K, Mamiya H, Uesato M, Murakami K, Kano M, Toyozumi T, Matsumoto Y, Suito H, Isozaki T, Ohira G, Hayashi H, Matsubara H. A case report of duodenal arteriovenous malformation: usefulness of intraoperative indocyanine green angiography for precise identification of the lesion. Surg Case Rep. 2022 Jan 4;8(1):4. doi: 10.1186/s40792-021-01356-8. PMID: 34982282; PMCID: PMC8727664.
Ishii A, Tsukamoto S, Mishina T, Izumi S, Nagai Y, Yamazaki M, Hino Y, Kayamori K, Oshima-Hasegawa N, Muto T, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Nakaseko C, Ikeda JI, Sakaida E. Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease. Leuk Res Rep;16:100278. 2021 Oct 29.
Nakaguro M, Mino-Kenudson M, Urano M, Ogawa I, Honda Y, Hirai H, Tanigawa M, Sukeda A, Kajiwara N, Ohira T, Ikeda N, Mikami Y, Tada Y, Ikeda JI, Matsubayashi J, Faquin WC, Sadow PM, Nagao T. Sialadenoma Papilliferum of the Bronchus: An Unrecognized Bronchial Counterpart of the Salivary Gland Tumor With Frequent BRAF V600E Mutations. Am J Surg Pathol;45(5):662-671. 2021 May 1.
Suzuki J, Kasai H, Terada J, Shikano K, Sasaki A, Suzuki H, Nakajima T, Kouchi Y, Shiina M, Kobayashi T, Ohwada C, Ikeda JI, Yoshino I, Tatsumi K. Bronchiolitis obliterans after stem cell transplantation for hematologic malignancies rescued by lung transplantation: A report of two cases. Respir Investig;59(4):559-563. 2021 Jul.
Ishiwata K, Suzuki S, Igarashi K, Ruike Y, Naito K, Ishida A, Deguchi-Horiuchi H, Fujimoto M, Koide H, Imamura Y, Sakamoto S, Ichikawa T, Ikeda JI, Yokote K. Characteristics of Benign Adrenocortical Adenomas with 18F-FDG PET Accumulation. Eur J Endocrinol. 2021 Jun 5;185(1):155-165.
Maimaiti M, Sakamoto S, Sugiura M, Kanesaka M, Fujimoto A, Matsusaka K, Xu M, Ando K, Saito S, Wakai K, Imamura Y, Nakayama K, Kanai Y, Kaneda A, Ikehara Y, Ikeda JI, Anzai N, Ichikawa T. The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2. Sci Rep. 2021 Jun 1;11(1):11478.
Hirono S, Gao Y, Matsutani T, Ikeda JI, Yokoo H, Iwadate Y. Metabolic, immunohistochemical, and genetic profiling of a cerebellar liponeurocytoma with spinal dissemination: a case report and review of the literature. Brain Tumor Pathol;38(3):257-262. 2021 Jul.
Naito K, Suzuki S, Ohwada C, Ishiwata K, Ruike Y, Ishida A, Deguchi-Horiuchi H, Fujimoto M, Koide H, Sakaida E, Horiguchi K, Iwadate Y, Tatsuno I, Inoshita N, Ikeda JI, Tanaka T, Yokote K. ICAM1-Negative Intravascular Large B-Cell Lymphoma of the Pituitary Gland: A Case Report and Literature Review. AACE Clin Case Rep;7(4):249-255. 2021 Feb 9.
Mishina T, Oshima-Hasegawa N, Tsukamoto S, Fukuyo M, Kageyama H, Muto T, Mimura N, Rahmutulla B, Nagai Y, Kayamori K, Hino Y, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Tsujimura H, Iseki T, Nakaseko C, Ikeda JI, Itami M, Yokote K, Ohara O, Kaneda A, Sakaida E. Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort. Br J Haematol;195(5):731-742. 2021 Dec.
Tokunaga M, Okimoto K, Akizue N, Ishikawa K, Hirotsu Y, Amemiya K, Ota M, Matsusaka K, Nishimura M, Matsushita K, Ishikawa T, Nagashima A, Shiratori W, Kaneko T, Oura H, Kanayama K, Ohta Y, Taida T, Saito K, Matsumura T, Chiba T, Mochizuki H, Arai M, Kato J, Ikeda JI, Omata M, Kato N. Genetic profiles of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients. Sci Rep;11(1):17671. 2021 Sep 3.
Kouchi Y, Yamashita K, Harada S, Shinomiya Y, Mishima T, Takano S, Matsusaka K, Nasu K, Ikeda JI, Ohtsuka M, Kishimoto T. Solid serous neoplasm of the pancreas with locally aggressive behaviors. Pathol Int;71(11):795-797. 2021 Nov.
Mukai S, Kanzaki H, Ogasawara S, Ishino T, Ogawa K, Nakagawa M, Fujiwara K, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Koroki K, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Muroyama R, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Shiina M, Ota M, Ikeda JI, Takiguchi Y, Ohtsuka M, Kato N. Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment. JGH Open;5(11):1266-1274. 2021 Oct 1.
Sazuka T, Fujimoto A, Sato H, Arai T, Imamura Y, Sakamoto S, Ikeda JI, Ichikawa T. Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. IJU Case Rep;4(6):355-358. 2021 Aug 16.
Ota M, Nakatani Y, Nakajima T, Hiroshima K, Motoi N, Yoshino I, Ikeda JI. Pulmonary microinvasive small cell carcinoma with extensive in situ component identified after photodynamic therapy for ‘squamous cell carcinoma in situ’: A case report. Histopathology;78(6):912-916. 2021 May.
Miyabe K, Saito M, Koyama K, Umakoshi M, Ito Y, Yoshida M, Kudo-Asabe Y, Saito K, Nanjo H, Maeda D, Matsusaka K, Goto A, Kono K. Collision of Epstein-Barr virus-positive and -negative gastric cancer, diagnosed by molecular analysis: a case report. BMC Gastroenterol;21(1):97. 2021 Mar 2.
Kimura K, Tsukamoto S, Miyazaki K, Kawajiri-Manako C, Ishii A, Rahmutulla B, Fukuyo M, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Ohwada C, Iseki T, Matsusaka K, Sanada M, Yokote K, Kaneda A, Ishida T, Suzuki K, Nakaseko C, Sakaida E. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing. Exp Hematol;101-102:34-41.e4. 2021 Sep.
Li W, Okabe A, Usui G, Fukuyo M, Matsusaka K, Rahmutulla B, Mano Y, Hoshii T, Funata S, Hiura N, Fukayama M, Tan P, Ushiku T, Kaneda A. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer. Cancer Sci;112(8):3349-3362. 2021 Aug.
Hata A, Nakajima T, Matsusaka K, Fukuyo M, Nakayama M, Morimoto J, Ito Y, Yamamoto T, Sakairi Y, Rahmutulla B, Ota S, Wada H, Suzuki H, Iwata T, Matsubara H, Ohara O, Yoshino I, Kaneda A. Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis. Int J Cancer;148(12):3008-3018. 2021 Jun 15.
Usui G, Matsusaka K, Mano Y, Urabe M, Funata S, Fukayama M, Ushiku T, Kaneda A. DNA Methylation and Genetic Aberrations in Gastric Cancer. Review Digestion;102(1):25-32. 2021.
Wakita S, Tamiya A, Higuchi Y, Kikuchi H, Kubota M, Ikegami S, Horiguchi K, Ikeda J, Iwadate Y. Metastasis of Renal Cell Carcinoma to Spinal Hemangioblastoma in a Patient with von Hippel-Lindau Disease: A Case Report. NMC Case Report Journal. 2021; 8:129-135
Ishizuka K, Uehara T, Arai M, Ikeda J, Hirose Y, Ikusaka M. Medical-type peritoneal mesothelioma leading to death two months after onset of fever of unknown origin. Radiol Case Rep. 2021 Dec 16;17(3):540-543.
Hata A, Nakajima T, Matsusaka K, Fukuyo M, Morimoto J, Yamamoto T, Sakairi Y, Rahmutulla B, Ota S, Wada H, Suzuki H, Matsubara H, Yoshino I, Kaneda A. A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis. Int J Cancer;146(2):388-399. 2020 Jan.
Ohshima K, Nojima S, Tahara S, Kurashige M, Kawasaki K, Hori Y, Taniguchi M, Yutaka Umakoshi Y, Okuzaki D, Wada N, Ikeda JI, Fukusaki E, Morii E. Serine racemase enhances growth of colorectal cancer by producing pyruvate from serine. Nat Metab;2(1):81–96, 2020 Jan.
Kurokawa T, Nakagawa T, Matsusaka K, Masaki F, Mima M, Misawa K, Rahmutulla B, Ikeda JI, Hanazawa T, Okamoto Y, Kaneda A. Establishment of epigenetic markers to predict irradiation efficacy against oropharyngel cancer. Cancer Sci;111(4):1407-1416, 2020 Apr.
Asakawa Y, Okabe A, Fukuyo M, Li W, Ikeda E, Mano Y, Funata S, Namba H, Fujii T, Kita K, Matsusaka K, Kaneda A. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3. Cancer Sci;111(5):1818-1828, 2020 May.
Nakagawa T, Matsusaka K, Misawa K, Ota S, Fukuyo M, Rahmutulla B, Kunii N, Sakurai D, Hanazawa T, Matsubara H, Okamoto Y, Kaneda A. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes. Int J Cancer;146(9):2460–2474, 2020 May.
Sata Y, Nakajima T, Fukuyo M, Matsusaka K, Hata A, Morimoto J, Rahmutulla B, Ito Y, Suzuki H, Yoshino I, Kaneda A. High expression of CXCL14 is a biomarker of lung adenocarcinoma with micropapillary pattern. Cancer Sci;111(7):2588-2597, 2020 Jul
Yashima S, Takaoka H, Iwahana T, Takahashi M, Kondo Y, Ueda H, Saito A, Ito Y, Motomura Y, Hiruta N, Ikeda J, Matsumiya G, Kobayashi Y. Coexistence of Marfan-Like Connective Tissue Disease with Morphologic Left Ventricular Non-Compaction. Intern Med;59(23):3039-3044, 2020 Aug.
Okabe A, Huang KK, Matsusaka K, Fukuyo M, Xing M, Ong X, Hoshii T, Usui G, Seki M, Mano Y, Rahmutulla B, Kanda T, Suzuki T, Rha SY, Ushiku T, Fukayama M, Tan P, Kaneda A. Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma. Nat Genet;52(9):919-930, 2020 Sep.
Yamamoto Y, Matsusaka K, Fukuyo M, Rahmutulla B, Matsue H, Kaneda A. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis. Cancer Med;9(19):7194-7204, 2020 Oct.
Usui H, Sato A, Ota M, Ikeda JI, Shozu M. Androgenetic Complete Hydatidiform Moles With p57KIP2-Positive Immunostaining. Am J Clin Pathol;154(6):776-783, 2020 Nov.
Suzuki S, Minamidate T, Shiga A, Ruike Y, Ishiwata K, Naito K, Ishida A, Deguchi H, Fujimoto M, Koide H, Tatsuno I, Ikeda JI, Yamazaki Y, Sasano H, Yokote K. Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma. BMC Endocr Disord;20(1):173, 2020 Nov.
Ota M, Nakatani Y, Nakajima T, Hiroshima K, Motoi N, Yoshino I, Ikeda JI. Pulmonary microinvasive small cell carcinoma with extensive in situ component identified after photodynamic therapy for 'squamous cell carcinoma in situ': A case report. Histopathology. 2020 Nov 30.
Muroyama Y, Tamiya H, Tanaka G, Tanaka W, Huang AC, Oldridge DA, Matsusaka K, Takazawa Y, Jo T, Ushiku T, Nagase T. Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1. Case Rep Oncol;3(3):1552-1559, 2020 Dec
8.Fukayama M, Abe H, Kunita A, Shinozaki-Ushiku A, Matsusaka K, Ushiku T, Kaneda A. Thirty years of Epstein-Barr virus-associated gastric carcinoma. Virchows Archiv;476:353-365, 2019
7.Tanaka Y, Seike S, Tomita K, Ikeda JI, Morii E, Tanaka-Isomura E, Kubo T. Possible malignant transformation of arteriovenous malformation to angiosarcoma: case report and literature review. J Surg Case Rep;12:1-3, 2019
6.Seki K, Ishikawa H, Hashimoto R, Mitsuhashi A, Ikeda JI, Shozu M. Development of localized cul-de-sac endometrioid carcinoma associated with deep infiltrating endometriosis during remission of early endometrial cancer. Gynecologic Oncology Reports;31:100526, 2019
5.Sekino N, Kano M, Sakata H, Murakami K, Toyozumi T, Matsumoto Y, Ryuzaki T, Ikeda JI, Ota M, Matsubara H. Caspase Recruitment Domain Family Member 9 expression is a promising biomarker in esophageal squamous cell carcinoma. Ann Gastroenterol Surg, 2019
4.Tsubosaka A, Matsushima J, Ota M, Suzuki M, Yonemori Y, Ota S, Yoshino I, Tsushima K, Tatsumi K, Nakatani Y. Whole-lung pathology of pleuroparenchymal fibroelastosis (PPFE) in an explanted lung: Significance of elastic fiber-rich, non-specific interstitial pneumonia-like change in chemotherapy-related PPFE. Pathol Int;69(9):547-555, 2019
3.Hashimoto T, Kurokawa Y, Takahashi T, Miyazaki Y, Tanaka K, Makino T, Yamasaki M, Nakajima K, Ikeda JI, Mori M, Doki Y. Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer. Gastric Cancer;22(4):785-792, 2019
2.Uchida G, Mino Y, Suzuki T, Ikeda JI, Suzuki T, Takenaka K, Setsuhara Y. Decomposition and oxidation of methionine and tryptophan following irradiation with a nonequilibrium plasma jet and applications for killing cancer cells. Sci Rep;9(1):6625, 2019
1.Tahara S, Nojima S, Ohshima K, Hori Y, Kurashige M, Wada N, Motoyama Y, Okuzaki D, Ikeda JI, Morii E. SDPR Regulates ALDH1 via ILK Signaling in Endometrioid Carcinoma Cells. Cancer Sci;110(5):1804-1813, 2019
8. Tanei T, Pradipta AR, Morimoto K, Fujii M, Arata M, Ito A, Yoshida M, Saigitbatalova E, Kurbangalieva A, Ikeda JI, Morii E, Noguchi S, Tanaka K. Cascade Reaction in Human Live Tissue Allows Clinically Applicable Diagnosis of Breast Cancer Morphology. Advanced Science, in press.
doi: 10.1002/advs.201801479
7. Wada N, Nojima S, Tahara SI, Ohshima K, Kurashige M, Kawasaki K, Tone M, Kusumoto S, Ikeda JI, Morii E. Effect of glutamine on lymphoplasmacytic lymphoma, especially on the viewpoint of the differentiation into vulnerable subpopulation. Pathol Res Pract. 2018; 214(10):1667-1674. Aug 27. pii: S0344-0338(18)30554-5.
doi: 10.1016/j.prp.2018.08.019.
6. Kurashige M, Kohara M, Ohshima K, Tahara S, Hori Y, Nojima S, Wada N, Ikeda JI, Miyamura K, Ito M, Morii E. Origin of cancer-associated fibroblasts and tumor-associated macrophages in humans after sex-mismatched bone marrow transplantation. Commun Biol, 2018 Sep 3;1:131.
doi: 10.1038/s42003-018-0137-0. eCollection 2018.
5. Uchida G, Ito T, Ikeda J, Suzkuki T, Takenaka K, Setsuhara Y. Effect of plasma-activated medium produced by direct irradiation on cancer cell killing.
Japanese Journal of Applied Physics (2018), in press. 57, 096201
4. Mishima C, Kagara N, Ikeda JI, Morii E, Miyake T, Tanei T, Naoi Y, Shimoda M, Shimazu K, Kim SJ, Noguchi S. Mutational analysis of AKT1 and PIK3CA in intraductal papillomas of the breast with special reference to cellular components. Am J Pathol, 2018;188:1106-1112.
doi: 10.1016/j.ajpath.2018.01.005.
3. Achiha T, Arita H, Kagawa N, Murase T, Ikeda JI, Morii E, Kanemura Y, Fujimoto Y, Kishima H. Enchondromatosis-associated oligodendroglioma: case report and literature review. Brain Tumor Pathology, 2018;35:36-40.
doi: 10.1007/s10014-017-0303-y.
2. Park H, Ohshima K, Nojima S, Tahara S, Kurashige M, Hori Y, Okuzaki D, Wada N, Ikeda JI, Morii E. Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing killer cell lectin-like receptor C3 expression by fumarate. Lab Invest, 2018;98:449-461.
doi: 10.1038/s41374-017-0017-0.
1. Ikeda J, Tanaka H, Ishikawa K, Sakakita H, Ikehara Y, Hori M. Plasma-activated medium (PAM) kills human cancer-initiating cells. Pathol Int, 2018:68:23-30.
doi: 10.1111/pin.12617.
64. Nojima S, Susaki EA, Yoshida K, Takemoto H, Tsujimura N, Iijima S, Takachi K, Nakahara Y, Tahara S, Ohshima K, Kurashige M, Hori Y, Wada N, Ikeda JI, Kumanogoh A, Morii E, Ueda HR. CUBIC pathology: three-dimensional imaging for pathological diagnosis. Sci Rep, 2017 Aug 24;7(1):9269.
doi: 10.1038/s41598-017-09117-0.
63. Matsui T, Mizuno H, Sudo T, Kikuta J, Haraguchi N, Ikeda JI, Mizushima T, Yamamoto H, Morii E, Mori M, Ishii M. Non-labeling multiphoton excitation microscopy as a novel diagnostic tool for discriminating normal tissue and colorectal cancer lesions. Sci Rep, 2017 Jul 31;7:6959.
doi:10.1038/s41598-017-07244-2
62. Chihara Y, Shimoda M, Hori A, Ohara A, Naoi Y, Ikeda JI, Kagara N, Tanei T, Shimomura A, Shimazu K, Kim SJ, Noguchi S. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Breast Cancer Res Treat, 2017 166(1):55-68.
doi: 10.1007/s10549-017-4382-6.
61. Wada N, Ikeda JI, Tanaka H, Sakakita H, Hori M, Ikehara Y, Morii E. Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma. Pathol Res Pract, 2017 Jul;213(7):773-777.
doi: 10.1016/j.prp.2017.04.003.
60. Ohshima K, Nojima S, Tahara S, Kurashige M, Hori Y, Hagiwara K, Okuzaki D, Oki S, Wada N, Ikeda JI, Kanai Y, Morii E. Argininosuccinate Synthase 1-Deficiency Enhances the Cell Sensitivity to Arginine through Decreased DEPTOR Expression in Endometrial Cancer. Sci Rep, 2017 Mar 30;7:45504.
doi: 10.1038/srep45504.
59. Hirose K, Okura M, Sato S, Murakami S, Ikeda JI, Noda Y, Fukuda Y, Morii E, Toyosawa S. Gnathic giant cell-rich conventional osteosarcoma with MDM2 and CDK4 gene amplification. Histopathology, 2017 Jun 70(7):1171-1173
doi: 10.1111/his.13141.
58. Ohno S, Ikeda JI, Naito Y, Okuzaki D, Sasakura T, Fukushima K, Nishikawa Y, Ota K, Kato Y, Wang M, Torigata K, Kasama T, Uchihashi T, Miura D, Yabuta N, Morii E, Nojima H. Comprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and cyclin G2. Sci Rep, 2016 Dec 16;6:39091.
doi: 10.1038/srep39091.
57. Ikeda JI, Kohara M, Tsuruta Y, Nojima S, Tahara S, Ohshima K, Kurashige M, Wada N, Morii E. Immunohistochemical analysis of the novel marginal-zone B-cell marker IRTA1 in malignant lymphoma. Hum Pathol, 2017;59:70-79.
doi: 10.1016/j.humpath.2016.09.011.
56. Tahara S, Nojima S, Ohshima K, Hori Y, Kurashige M, Wada N, Ikeda J, Morii E. S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is associated with the ‘MELF’ pattern. Cancer Sci, 2016;109:1345-1352.
doi: 10.1111/cas.12999.
55．Zhan M, Hori Y, Wada N, Ikeda J, Hata Y, Osuga K, Morii E. Angiogenic factor with G-patch and FHA domain 1 (AGGF1) expression in human vascular lesions. Acta Histochem Cytochem, 2016;49:75-81.
doi: 10.1267/ahc.15035.
54. Ikeda JI, Wada N, Nojima S, Tahara S, Tsuruta Y, Oya K, Morii E. ID1 upregulation and FoxO3a downregulation by Epstein-Barr virus-encoded LMP1 in Hodgkin lymphoma. Mol Clin Oncol, 2016;5:562-566.
53. Miyamoto K, Ikehara S, Takei H, Akimoto Y, Sakakita H, Ishikawa K, Ueda M, Ikeda J, Yamagishi M, Kim J, Yamaguchi T, Nakanishi H, Shimizu N, Hori M, Ikehara Y. Red Blood Cell Coagulation Induced by Low-temperature Plasma Treatment. Arch Biochem Biophys, 2016;605:95-101.
doi: 10.1016/j.abb.2016.03.023.
52．Wada N, Ikeda J, Nojima S, Tahara S, Ohshima K, Okuzaki D, Morii E. Requirement of CXCL12-CXCR7 signaling for CD20- CD138- double negative population in lymphoplasmacytic lymphoma. Lab Invest, 2016;96:517-525.
doi: 10.1038/labinvest.2016.28.
51. Ikehara S, Sakakita H, Ishikawa K, Yamaguchi T, Kim J, Ueda M, Ikeda J, Nakanishi H, Shimizu N, Hori M, Ikehara Y. Plasma blood coagulation without involving the activation of platelets and coagulation factors. Plasma Process Polym, 2015;12:1348-1353.
50. Ikeda J, Tsuruta Y, Nojima S, Sakakita H, Hori M, Ikehara Y. Anti-cancer effects of nonequilibrium atmospheric pressure plasma on cancer-initiating cells in human endometrioid adenocarcinoma cells. Plasma Process Polym, 2015;12:1370-1376.
DOI: 10.1002/ppap.201500097
49. Jokoji R, Ikeda J, Tsujimoto M, Morii E. Epithelioid Rhabdomyosarcoma; A case report with immunohistochemical and molecular study. Diagn Pathol, 2015;10(1):124.
doi: 10.1186/s13000-015-0349-2.
48. Zhan M, Ikeda JI, Wada N, Hori Y, Nojima S, Tahara S, Ueda Y, Yoshino K, Kimura T, Morii E. Prognostic significance of a component of Hippo pathway, TAZ, in human endometrioid adenocarcinoma of uterus. Oncol Lett, 2016;11: 3611-3616.
47. Matsui T, Hori Y, Nagano H, Eguchi H, Marubashi S, Wada H, Wada N, Ikeda JI, Sakamoto M, Morii E. Poorly differentiated hepatocellular carcinoma accompanied by anti-Hu antibody-positive paraneoplastic peripheral neuropathy. Pathol Int, 2015;65(7):388-392.
doi: 10.1111/pin.12304.
46．Kakumoto K, Ikeda J, Okada M, Morii E, Oneyama C. mLST8 promotes mTOR-mediated tumor progression. PLoS ONE, 2015 Apr 23;10(4):e0119015 doi:10.1371/journal.pone.0119015. eCollection 2015.
45. Nishibayashi A, Kubo T, Matsuda K, Ikeda JI, Hosokawa K. Bronchogenic cyst in the chin region. J Dermatol, 2015;42(5):544-545.
doi: 10.1111/1346-8138.12816.
44．Ikeda J. Effect of non-equilibrium atmospheric pressure plasma on cancer initiating cells. Plasma Medicine, 2014;4(1-4):49-56
DOI: 10.1615/PlasmaMed.2014011935
43. Wang Y, Jiang Y, Ikeda J, Tian T, Sato A, Ohtsu H, Morii E . Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line. Cancer Med, 2014;3(5):1126-1135
doi: 10.1002/cam4.296.
42.Oneyama C, Kito Y, Asai R, Ikeda J, Yoshida T, Okuzaki D, Kokuda R, Kakumoto K, Takayama K, Inoue S, Morii E, Okada M. MiR-424/503-mediated Rictor upregulation promotes tumor progression. PLoS ONE, 2013 Nov 11;8(11):e80300. doi: 10.1371/journal.pone.0080300. eCollection 2013)
41.Wada N, Zhan M, Hori Y, Honma K, Ikeda JI, Morii E. Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line. Lab Invest, 2014;94(1):79-88
doi: 10.1038/labinvest.2013.129.
40.Wang Y, Jiang Y, Tian T, Hori Y, Wada N, Ikeda J, Morii E. Inhibitory effect of Nodal on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma of uterus. Biochem Biophys Res Commun, 2013;440(4): 731-736
doi: 10.1016/j.bbrc.2013.09.139.
39.Ikeda J, Tian T, Wang Y, Hori Y, Honma K, Wada N, Morii E. Expression of FoxO3a in clinical cases of malignant lymphoma. Pathol Res Pract, 2013;209(11):716-720
doi: 10.1016/j.prp.2013.08.003.
38.Tian T, Ikeda JI, Wang Y, Mamat S, Luo W, Aozasa K, Morii E. Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumorigenesis in cancers. Eur J Cancer, 2012;48(15):2462-2473
doi: 10.1016/j.ejca.2012.01.018.
37.Mamat S, Ikeda J, Tian T, Wang Y, Luo W, Aozasa K, Morii E. Transcriptional regulation of aldehyde dehydrogenase 1A1 gene by alternative spliced forms of nuclear factor Y in tumorigenic population of endometrial adenocarcinoma. Genes Cancer 2011;2(10):979-984
doi: 10.1177/1947601911436009.
36.Ikeda J, Mamat S, Tian T, Wang Y, Luo W, Rahadiani N, Aozasa K, Morii E. Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells. Lab Invest 2012;92(4):606-614
doi: 10.1038/labinvest.2012.4.
35.Zaki MA, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, Tatsumi Y, Tsukaguchi M, Take H, Tsudo M, Morii E, Aozasa K. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch, 2011; 459(4):361-366
doi: 10.1007/s00428-011-1140-8.
34.Oneyama C, Morii E, Okuzaki D, Takahashi Y, Ikeda J, Wakabayashi N, Akamatsu H, Tsujimoto M, Nishida T, Aozasa K, Okada M. MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression. Oncogene 2012;31(13):1623-1635
doi: 10.1038/onc.2011.367.
33.Wang Y, Ikeda J, Rahadiani N, Mamat S, Ueda Y, Tian T, Enomoto T, Kimura T, Aozasa K, Morii E. Prognostic significance of elongator protein 3 expression in endometrioid adenocarcinoma. Oncol Lett 2012;3:25-29
32.Fujita S, Morii E, Rahadiani N, Wada N, Hori Y, Ikeda J, Aozasa K. Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma. Exp Ther Med 2011;2:591-594.
31.Chihara T, Wada N, Ikeda J, Fujita S, Hori Y, Ogawa H, Sugiyama H, Nomura S, Matsumura I, Hino M, Kanakura Y, Morii E, Aozasa K. Frequency of intravascular large B-cell lymphoma in Japan: Study of the Osaka Lymphoma Study Group. J Hematol Oncol 2011;4(1):14.
doi: 10.1186/1756-8722-4-14.
30.Oneyama C, Ikeda J, Okuzaki D, Suzuki K, Kanou T, Shintani Y, Morii E, Okumura M, Aozasa K, Okada M. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways. Oncogene 2011;30:3489-3501
doi: 10.1038/onc.2011.63.
29.Zaki MA, Wada N, Kohara M, Ikeda J, Hori Y, Fujita S, Ogawa H, Sugiyama H, Hino M, Kanakura Y, Morii E, Aozasa K. Presence of B-cell clones in T-cell lymphoma. Eur J Haematol 2011;86:412-419
doi: 10.1111/j.1600-0609.2011.01597.x.
28.Rahadiani N, Ikeda JI, Mamat S, Matsuzaki S, Ueda Y, Umehara R, Tian T, Yi W, Enomoto T, Kimura T, Aozasa K, Mori E. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications. Cancer Sci 2011;102:903-908
doi: 10.1111/j.1349-7006.2011.01864.x.
27.Wada N, Ikeda J, Hori Y, Fujita S, Ogawa H, Soma T, Sugiyama H, Fukuhara S, Kanamaru A, Hino M, Kanakura Y, Morii E, Aozasa K. Epstein-Barr virus in diffuse large B-cell lymphoma in immunocompetent patients in Japan is as low as in Western countries. J Med Virol 2011;83(2):317-321
doi: 10.1002/jmv.21967.
26.Ikeda J, Mamat S, Tian T, Wang Y, Rahadiani N, Aozasa K, Morii E. Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines. Am J Pathol 2010;177(6):3081-3088
doi: 10.2353/ajpath.2010.100089.
25.Wada N, Kohara M, Ikeda J, Hori Y, Fujita S, Okada M, Ogawa M, Sugiyama H, Fukuhara S, Kanamaru A, Hino M, Kanakura Y, Morii E, Aozasa K. Diffuse large B-cell lymphoma in the spinal epidural space: A study of the Osaka Lymphoma Study Group. Pathol Res Pract 2010;206(7):439-444
doi: 10.1016/j.prp.2010.02.003.
24.Mamat S, Ikeda J, Enomoto T, Ueda Y, Rahadiani N, Tian T, Wang Y, Qiu Y, Kimura T, Aozasa K, Morii E. Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma. Oncol Rep 2010;23(5):1221-1227
23.Rahadiani N, Ikeda JI, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma. Ann Surg Oncol 2010;17(5):1311-1323
doi: 10.1245/s10434-009-0895-5.
22.Ikeda J, Yamauchi A, Hoshida Y, Okamura S, Hashimoto K, Aozasa K, Morii E. Peripheral T-cell lymphoma developing at ileocolonic anastomosis site after colectomy for adenocarcinoma. Pathol Res Pract 2010;206(6):376-378
doi: 10.1016/j.prp.2009.08.001.
21.Wada N, Ikeda J, Kohara M, Ogawa H, Hino M, Fukuhara S, Kanamaru A, Sugiyama H, Kanakura Y, Morii E, Aozasa K. Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group. Virchows Arch 2009; 455(3):285-93
doi: 10.1007/s00428-009-0827-6.
20.Oda T, Tian T, Inoue M, Ikeda JI, Qiu Y, Okumura M, Aozasa K, Morii E. Tumorigenic role of orphan nuclear receptor NROB1 in lung adenocarcinoma. Am J Pathol 2009; 175(3):1235-45
doi: 10.2353/ajpath.2009.090010.
19.Oda T, Morii E, Inoue M, Ikeda JI, Aozasa K, Okumura M. Prognostic significance of heat shock protein 105 in lung adenocarcinoma. Mol Med Reports 2009;2:603-607
doi: 10.3892/mmr_00000144.
18.Nakamichi I, Shimazu K, Ikeda J, Yamauchi A, Ishiko J, Mizuki M, Kanakura Y, Aozasa K. Intravascular lymphomatosis initially suspected from uterine cytology: a case report. Acta Cytol 2009;53(2):198-200
17.Nakamichi N, Morii E, Ikeda JI, Qiu Y, Mamat S, Tian T, FUkuhara S, Aozasa K. Synergistic effect of interleukin-6 and endoplasmic reticulum stress inducers on the high level of ABCG2 expression in plasma cells. Lab Invest 2009;89(3):327-336
doi: 10.1038/labinvest.2008.157.
16.Ikeda JI, Oda T, Inoue M, Uekita T, Sakai R, Okumura M, Aozasa K, Morii E. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci 2009;100(3):429-433
doi: 10.1111/j.1349-7006.2008.01066.x.
15.Ikeda J, Morii E, Liu Y, Qiu Y, Nakamichi N, Jokoji R, Miyoshi Y, Noguchi S, Aozasa K. Prognostic significance of CD55 expression in breast cancer. Clin Cancer Res 2008; 14(15):4780-4786
doi: 10.1158/1078-0432.CCR-07-1844.
14.Yamauchi A, Ikeda J, Nakamichi I, Kohara M, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A, Aozasa K. Diffuse large B-cell lymphoma showing an interfollicular pattern of proliferation: a study of the Osaka Lymphoma Study Group. Histopathology 2008;52(6):731-737
doi: 10.1111/j.1365-2559.2008.03018.x.
13.Kohmo S, Tachibana I, Osaki T, Goya S, Matsuoka H, Kijima T, Yoshida M, Kumagai T, Ikeda J, Aozasa K, Kawase I. Multiple organ mucosa-associated lymphoid tissue lymphoma presenting with lymphangitic pattern of spread in the lung.
J Thorac Oncol 2007;2(11):1057-1059
12.Ikeda J, Morii E, Yamauchi A, Kohara M, Hashimoto N, Yoshikawa H, Iwasaki M, Aozasa K. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type developing in gonarthritis deformans.
J Clin Oncol 2007;25(27):4310-4312
11.Ch'ng ES, Hoshida Y, Iizuka N, Morii E, Ikeda JI, Yamamoto A, Tomita Y, Hanasaki H, Katsuya T, Maeda K, Ohishi M, Rakugi H, Ogihara T, Aozasa K. Composite malignant pheochromocytoma with malignant peripheral nerve sheath tumour: a case with 28 years of tumour-bearing history.
Histopathology 2007;51(3):420-422
10.Yamano T, Morii E, Ikeda J, Aozasa K. Granulocyte colony-stimulating factor production and rapid progression of gastric cancer after histological change in the tumor.
Jpn J Clin Oncol 2007;37(10):793-796
9.Yamauchi A, Fujita S, Ikeda J, Nakamichi I, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A, Aozasa K. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group.
Am J Hematol 2007;82:893-897
8.Xu JX, Morii E, Liu Y, Nakamichi N, Ikeda J, Kimura H, Aozasa K. High tolerance to apoptotic stimuli induced by serum depletion and ceramide in side-population cells: high expression of CD55 as a novel character for side-population.
Exp Cell Res 2007;313:1877-1885
7.Ikeda J, Morii E, Tomita Y, Zhang B, Tokunaga T, Inoue M, Minami M, Okumura M, Aozasa K. Mediastinal lymphangiomatosis coexisting with occult thymic carcinoma.
Virchows Arch 2007;450:211-214
6.Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T, Aozasa K.Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
J Rheumatol 2007;34:322-331
5.Ngan CY, Yamamoto H, Seshimo I, Tsujino T, Man-i M, Ikeda JI, Konishi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer.
Br J Cancer 2007;96:986-92
4.Kimura H, Morii E, Ikeda JI, Ezoe S, Xu JX, Nakamichi N, Tomita Y, Shibayama H, Kanakura Y, Aozasa K. Role of DNA methylation for expression of novel stem cell marker CDCP1 in hematopoietic cells.
Leukemia 2006;20:1551-1556
3.Ikeda JI, Morii E, Kimura H, Tomita Y, Takakuwa T, Hasegawa JI, Kim YK, Miyoshi Y, Noguchi S, Nishida T, Aozasa K. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.
J Pathol 2006;210:75-84
2.Ikeda J, Morii E, Tomita Y, Xu JX, Kimura H, Kohara M, Hoshida Y, Aozasa K. Methotrexate-associated lymphoproliferative disorder mimicking composite lymphoma.
Int J Hematol 2006;83:363-5
1.Nishiu M, Tomita Y, Nakatsuka S, Takakuwa T, Iizuka N, Hoshida Y, Ikeda J, Iuchi K, Yanagawa R, Nakamura Y, Aozasa K. Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation.
Cancer Sci 2004;95:828-34
